ClinConnect ClinConnect Logo
Search / Trial NCT06272786

Suprascapular Nerve Block in Patients Rehabilitated After Arthroscopic Rotator Cuff Repair

Launched by KIRSEHIR AHI EVRAN UNIVERSITESI · Feb 16, 2024

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Rotator Cuff Tears Pain Nerve Block Rehabilitation

ClinConnect Summary

This clinical trial is studying the use of a suprascapular nerve block, which is an injection aimed at helping patients recover from rotator cuff repair surgery. The goal is to see if this method, guided by ultrasound (a type of imaging), can improve shoulder rehabilitation and reduce pain more effectively than traditional approaches. The trial is currently looking for participants who have had rotator cuff surgery within the last week.

To be eligible for the trial, participants must be between the ages of 65 to 74 or younger than 23, and they should not have had any previous surgeries on the same shoulder. People with certain medical conditions, such as neurological diseases, chronic pain requiring strong medications, or cognitive impairments, will not be able to join. Those who participate can expect to receive an injection that may help ease their pain and improve their recovery after surgery. Overall, this trial aims to provide valuable insights into better pain management and rehabilitation for shoulder surgery patients.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • -Having undergone arthroscopic rotator cuff repair surgery within the last week
  • Exclusion Criteria:
  • History of previous surgery on the same shoulder
  • History of systemic inflammatory rheumatological disease
  • Neurological diseases with muscle weakness in the upper extremity (MS, ALS, Muscular -Dystrophy)
  • History of malignancy, pregnancy, breastfeeding
  • Use of steroids or immunosuppressive drugs
  • History of allergic reactions to local analgesics
  • Fibromyalgia syndrome
  • Chronic painful conditions that require opioid use
  • Presence of known psychiatric disease
  • Cognitive impairment (Mini Mental Test Score \<23)

About Kirsehir Ahi Evran Universitesi

Kırşehir Ahi Evran University is a distinguished academic institution in Turkey, renowned for its commitment to advancing medical research and education. As a clinical trial sponsor, the university leverages its expertise in various healthcare fields to facilitate innovative research initiatives aimed at improving patient outcomes and advancing scientific knowledge. With a focus on collaboration and ethical standards, Kırşehir Ahi Evran University actively engages in clinical trials that encompass a broad spectrum of medical disciplines, fostering an environment that encourages rigorous scientific inquiry and the translation of research findings into clinical practice.

Locations

Kirşehir, City Centre, Turkey

Patients applied

0 patients applied

Trial Officials

Basak Cigdem Karacay, Asst Prof

Principal Investigator

Kirsehir Ahi Evran University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported